(1 - 21 von 23
)
Ovarian Cancer Collaboration with the Medical University of Vienna |...
www.technologynetworks.com
Collaboration agreement to investigate the clinical use of the Parsortix system for ovarian cancer.
Researchers Isolate Possible Ovarian Cancer Biomarkers; Find...
news.ncsu.edu
Robert Zeillinger says: October 1, at 2:39 pm. One has to be very careful in interpreting such data. Stage I disease usually is a special ...
Researchers successfully use Parsortix system in ovarian cancer drug...
medicalxpress.com
Robert Zeillinger, Head of the Molecular Oncology Group at the Medical University of Vienna. 'This opens up completely new approaches to ...
Parsortix Blood Test Out-performs CA125 in Detecting Ovarian Cancer
ovariancancernewstoday.com
Studies in the U.S. and Europe successfully demonstrated the potential of a Parsortix blood test to out-perform current tests in diagnosing ovarian cancer.
sortiert nach Relevanz / Datum